Thermo Fisher Scientific Vanquish Flex UHPLC System

Overview

The Thermo Fisher Scientific Vanquish Flex UHPLC System is a modular, high-performance liquid chromatography platform engineered for method development, quality control, and biopharmaceutical characterization under regulated and research environments. Built upon the proven Vanquish architecture, this system implements advanced low-dispersion fluidics, pressure-robust gradient delivery, and thermally stabilized detection to deliver reproducible separations at ultra-high pressures (up to 100 MPa / 1000 bar). Its core operational principle relies on high-efficiency reversed-phase, hydrophilic interaction (HILIC), size-exclusion (SEC), and ion-exchange chromatography—enabled by precise mobile phase mixing, sub-microliter injection precision, and real-time pressure/temperature compensation algorithms. Designed for seamless integration into GLP/GMP-compliant laboratories, the Vanquish Flex supports audit-ready data acquisition, electronic signatures, and full traceability in alignment with FDA 21 CFR Part 11 and EU Annex 11 requirements.

Key Features

• Quaternary gradient pump with active solvent selection and pulse-free flow delivery across 0.001–8 mL/min, optimized for both narrow-bore and standard columns (2.1 mm to 4.6 mm i.d.)
• High-capacity autosampler with 8832-position tray support, featuring dual-needle design for simultaneous sample loading and injection, minimizing carryover (<0.005%) and enabling uninterrupted overnight runs
• Column compartment with active pre-heating and post-cooling zones, maintaining thermal stability from 5 °C to 120 °C with ±0.1 °C accuracy and <0.2 °C axial gradient
• UV-Vis diode array detector (DAD) with 190–680 nm spectral range, 200 Hz acquisition rate, and 10 mm pathlength flow cell for enhanced sensitivity and peak fidelity
• Modular detector compatibility—including optional fluorescence (FLR), charged aerosol (CAD), and mass spectrometry (MS) interfaces—enabling multi-modal detection strategies without hardware reconfiguration
• Fully integrated SMART (System Management and Real-Time) diagnostics, providing predictive maintenance alerts, pressure transient analysis, and automatic leak detection

Sample Compatibility & Compliance

The Vanquish Flex accommodates diverse sample matrices including monoclonal antibodies (mAbs), antibody-drug conjugates (ADCs), peptides, small molecules, oligonucleotides, and excipients. Its bio-inert fluidic path—comprising titanium, PEEKsil, and sapphire components—ensures minimal surface adsorption and metal-catalyzed degradation during extended gradient runs. The system complies with ISO/IEC 17025:2017 for testing laboratories and supports validation protocols per USP , ICH Q2(R2), and ASTM D7819 for chromatographic method robustness. All firmware and software modules are validated for use in regulated environments and include full electronic record retention, user access controls, and immutable audit trails.

Software & Data Management

Controlled via Thermo Scientific Chromeleon™ CDS (Chromatography Data System) 7.3 or later, the Vanquish Flex enables method transfer, sequence scheduling, and automated report generation with configurable templates compliant with ALCOA+ principles. Chromeleon integrates natively with Thermo Scientific AppsLab—a searchable online repository of peer-reviewed application notes, validated methods, chromatograms, and processing parameters—for rapid method adoption and cross-laboratory harmonization. Data integrity safeguards include role-based permissions, digital signatures, version-controlled method storage, and encrypted database backups. Optional Chromeleon eWorkflow modules support automated QC pass/fail logic, trend analysis, and statistical process control (SPC) charting aligned with ISO 9001 and ICH Q5E.

Applications

• Biopharmaceutical purity assessment: intact mass analysis, charge variant profiling, and aggregate quantification using SEC-MALS or IEX-DAD
• Small-molecule impurity profiling per ICH Q3B(R3), including genotoxic impurity screening at sub-ppm levels
• Stability-indicating method development for forced degradation studies (oxidative, acidic, basic, thermal)
• Pharmacokinetic (PK) and toxicokinetic (TK) bioanalysis in plasma and tissue homogenates using protein precipitation or SPE workflows
• Peptide mapping and deamidation monitoring in therapeutic proteins via tryptic digestion followed by RPLC-DAD/FLR
• Excipient compatibility testing in formulation development, including polysorbate degradation product identification

FAQ

What regulatory standards does the Vanquish Flex UHPLC support for data integrity?

The system meets FDA 21 CFR Part 11, EU Annex 11, and ISO/IEC 17025 requirements through Chromeleon CDS, including electronic signatures, audit trail logging, and secure user authentication.
Can the Vanquish Flex be integrated with mass spectrometry platforms?

Yes—it features standardized LC-MS interface ports (e.g., ESI, APCI) and supports direct coupling with Thermo Scientific Orbitrap and triple quadrupole mass spectrometers via dedicated driver modules.
Is column oven temperature uniformity verified across the full 5–120 °C range?

Yes—thermal mapping reports confirm axial and radial uniformity within ±0.15 °C at all setpoints, validated per USP Analytical Instrument Qualification guidelines.
How does the quaternary pump maintain gradient accuracy at ultra-low flow rates (e.g., 0.001 mL/min)?

It employs dual-piston syringe technology with real-time pressure feedback and adaptive dwell volume compensation, ensuring ≤0.15% RSD gradient composition error even at nanoliter-scale flows.
Does the system support remote monitoring and troubleshooting?

Chromeleon Cloud Connect enables secure remote diagnostics, live instrument status dashboards, and proactive service ticket initiation—all accessible via browser-based client without local network exposure.